Analogic (ALOG) Earning Somewhat Positive News Coverage, Report Finds

News coverage about Analogic (NASDAQ:ALOG) has trended somewhat positive this week, Accern Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Analogic earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news headlines about the medical research company an impact score of 46.1113660222472 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the headlines that may have effected Accern Sentiment’s scoring:

Shares of Analogic (ALOG) opened at $82.15 on Friday. The company has a market cap of $1,020.00, a PE ratio of 49.29, a P/E/G ratio of 4.22 and a beta of 0.85. Analogic has a fifty-two week low of $66.00 and a fifty-two week high of $93.55.

A number of research analysts have recently issued reports on ALOG shares. Jefferies Group started coverage on shares of Analogic in a research note on Wednesday, August 9th. They set a “hold” rating and a $75.00 price target on the stock. Zacks Investment Research upgraded shares of Analogic from a “hold” rating to a “buy” rating and set a $93.00 price target on the stock in a research note on Tuesday, October 10th. Four analysts have rated the stock with a hold rating, Analogic currently has a consensus rating of “Hold” and a consensus target price of $85.25.

COPYRIGHT VIOLATION WARNING: This news story was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Insider Buying and Selling by Quarter for Analogic (NASDAQ:ALOG)

What are top analysts saying about Analogic Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Analogic Co. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit